NCT00187512View on ClinicalTrials.gov

SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era

RecruitingOBSERVATIONAL
Enrollment

2,500

Participants

Timeline

Start Date

March 31, 2000

Primary Completion Date

December 31, 2032

Study Completion Date

December 31, 2033

Conditions
HIV Infections
Trial Locations (1)

94110

RECRUITING

San Francisco General Hospital, San Francisco

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

University of California, San Francisco

OTHER